Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab

BACKGROUND: There is a critical need for predictive/resistance biomarkers for VEGF inhibitors to optimise their use. METHODS: Blood samples were collected during and following treatment and, where appropriate, upon progression from ovarian cancer patients in ICON7, a randomised phase III trial of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Cong, Clamp, Andrew, Backen, Alison, Berzuini, Carlo, Renehan, Andrew, Banks, Rosamonde E, Kaplan, Richard, Scherer, Stefan J, Kristensen, Gunnar B, Pujade-Lauraine, Eric, Dive, Caroline, Jayson, Gordon C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947705/
https://www.ncbi.nlm.nih.gov/pubmed/27351218
http://dx.doi.org/10.1038/bjc.2016.194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947705/
https://www.ncbi.nlm.nih.gov/pubmed/27351218
http://dx.doi.org/10.1038/bjc.2016.194

Ejemplares similares